Antimicrobial therapy for pediatric patients (Q33429288)

26 July 2017

1 reference

title

Antimicrobial therapy for pediatric patients (English)

1 reference

26 July 2017

Steele RW

1

1 reference

26 July 2017

Kearns GL

series ordinal

2

1 reference

26 July 2017

publication date

1 October 1989

1 reference

Pediatric Clinics of North America

26 July 2017

published in

1 reference

26 July 2017

volume

36

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

1321-1349

1 reference

Differential effects of chloramphenicol and its nitrosoanalogue on protein synthesis and oxidative phosphorylation in rat liver mitochondria

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Arthropathy in a patient with cystic fibrosis taking ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Clinical Pharmacokinetics of Chloramphenicol and Chloramphenicol Succinate

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Clinical pharmacokinetics of the third generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Effects of Moxalactam on Blood Coagulation and Platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Moxalactam in Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Defects in vitamin K-dependent carboxylation associated with moxalactam treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Why Monitor Serum Levels of Gentamicin?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Ciprofloxacin pharmacokinetics in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Chloramphenicol and cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Clinical Pharmacology of Aminoglycoside Antibiotics in Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Bilirubin transport in the newborn infant, reviewed with relation to kernicterus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Cobinding of bilirubin and sulfonamide and of two bilirubin molecules to human serum albumin: a site model

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacology of Hearing and Ototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Interaction between chloramphenicol and paracetamol

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Supra-normal sensitivity to ototoxic antibiotic of the developing rat cochlea

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Cefoperazone pharmacokinetics in acute childhood meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Moxalactam therapy of Haemophilus influenzae type b meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

A critique of semiautomated susceptibility systems

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Significance of Serum Protein and Tissue Binding of Antimicrobial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Antibiotic-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Fatal aplastic anemia following apparent “dose-related” chloramphenicol toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics of ciprofloxacin in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Latamoxef and the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Moxalactam as an alternative to gentamicin in the treatment of clinically infected neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Drug therapy. Beta-lactam antibiotics (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Role of pharmacokinetics in the outcome of infections

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Postnatal changes in the ability of plasma albumin to bind bilirubin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

A follow-up study on the cochlear, vestibular and renal function in children treated with gentamicin in the newborn period

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Acidosis as a presenting feature of chloramphenicol toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Protein binding of drugs in plasma, interstitial fluid and tissues: Effect on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Platelet-mediated bleeding caused by broad-spectrum penicillins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Mode of action, and in vitro and in vivo activities of the fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Management of chloramphenicol intoxication in infancy by charcoal hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The effect of semisynthetic penicillins on the binding of bilirubin by neonatal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Cardiac function and acute chloramphenicol toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Ciprofloxacin-induced hematuria

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Displacement effect of ceftriaxone on bilirubin bound to human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Age-associated changes in ceftriaxone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The bacterial degradation of chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Ototoxicity of Gentamicin in Man: A Survey and Controlled Analysis of Clinical Experience in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Increase in bilirubin-binding affinity of serum with age of infant

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Prospective comparative trial of moxalactam versus amplicillin or chloramphenicol for treatment of haemophilus influenzae type b meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Absence of a pharmacokinetic interaction between chloramphenicol and acetaminophen in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Interaction of chloramphenicol and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Chloramphenicol toxicity in a neonate treated with exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Interaction of chloramphenicol with phenytoin and phenobarbital. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Adverse drug reactions in general pediatric outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacologic interactions among chloramphenicol, phenytoin and phenobarbital.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Aminoglycoside treatment and renal prostaglandin excretion in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Potentiation of neuromuscular weakness in infant botulism by aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetic and Clinical Evaluation of Moxalactam in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Glomerular filtration rate during the period of adaptation to extrauterine life

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Rationale for monitoring free drug levels

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Latamoxef-associated hypoprothrombinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics of ceftriaxone in neonates and infants with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Treatment of an infant with severe chloramphenicol intoxication using charcoal-column hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Intramitochondrial localization of delta-aminolaevulate synthetase and ferrochelatase in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Comparative toxicities of third-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Concordance for drug-induced aplastic anemia in identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Side effects of cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The dissociation of bilirubin from albumin and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Interindividual differences in the effect of drugs on bilirubin plasma binding in newborn infants and in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Hematologic consequences of chloramphenicol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Cefoperazone-induced coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Multiple intravenous dose pharmacokinetics of ceftriaxone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Chloramphenicol: new perspectives on an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Interactions among chloramphenicol, phenytoin, and phenobarbital in a pediatric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Effect of rifampin on chloramphenicol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Are measurements of urine enzymes useful during aminoglycoside therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Ceftriaxone A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Bilirubin binding in premature infants from birth to 3 months

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Effect of cephalosporins on bilirubin-albumin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

1 reference

7 January 2021

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Potential for bleeding with the new beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Single-dose ceftriaxone kinetics in the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Renal clearance and tissue accumulation of gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Gentamicin disposition and tissue accumulation on multiple dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Aminoglycoside nephrotoxicity and its predictability

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Mechanism of Cephalosporin-induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Comparative effects of cefoxitin and cefotetan on vitamin K metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Exchange transfusion in acute chloramphenicol toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Comparative toxicity of gentamicin and cefotetan

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

1 reference

7 January 2021

Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Therapeutic initiatives for the avoidance of aminoglycoside toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

The ototoxic effects of kanamycin sulfate in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

Chloramphenicol: relation of structure to activity and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

DNA damage induced by chloramphenicol and its nitroso derivative: damage in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936770-0

7 January 2021

10.1016/S0031-3955(16)36770-0

Identifiers

DOI

0 references

1 reference